GlassScriptPhysician profile
Megan Griffith
NPI 1821676511
$4,671.60
in general payments reported to CMS, 2019-2025
35 companies · $1,331 in 2025
The $1,331 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.28 · 2022: $654 · 2023: $1,501 · 2024: $1,142 · 2025: $1,331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,974.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $827.15 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $618.56 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $569.03 | 2022-2025 | |
| Lilly USA, LLC | $546.38 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $281.71 | 2023-2025 | Lifevest |
| Neurocrine Biosciences, INC. | $181.05 | 2022-2024 | Ingrezza |
| Astellas Pharma US INC | $179.16 | 2023-2025 | Veozah |
| Pfizer INC. | $163.70 | 2022-2025 | |
| Merz North America, INC. | $149.00 | 2021-2022 | |
| Exact Sciences Corporation | $123.92 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $114.02 | 2023-2024 | Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $111.07 | 2022-2024 | |
| Intuitive Surgical, INC. | $103.63 | 2024 | |
| Sumitomo Pharma America, INC. | $78.93 | 2023-2024 | Gemtesa |
| Glaxosmithkline, LLC. | $71.95 | 2023-2025 | Arexvy, Shingrix, Trelegy Ellipta |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.